Package 72205-285-05

{"route": ["ORAL"], "spl_id": "a87a3fa5-28cb-42be-9039-af800a7c482c", "openfda": {"upc": ["0372205284050", "0372205284920", "0372205030923", "0372205285057", "0372205285606"], "unii": ["EM5OCB9YJ6"], "rxcui": ["1100075", "1918042"], "spl_set_id": ["88d05db3-8bdc-47f1-bb00-6b4a71f98609"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (72205-285-05)", "package_ndc": "72205-285-05", "marketing_start_date": "20240524"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (72205-285-60)", "package_ndc": "72205-285-60", "marketing_start_date": "20240524"}], "brand_name": "Abiraterone", "product_id": "72205-285_a87a3fa5-28cb-42be-9039-af800a7c482c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 17A1 Inhibitor [EPC]", "Cytochrome P450 17A1 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "product_ndc": "72205-285", "generic_name": "Abiraterone acetate", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abiraterone", "active_ingredients": [{"name": "ABIRATERONE ACETATE", "strength": "500 mg/1"}], "application_number": "ANDA210686", "marketing_category": "ANDA", "marketing_start_date": "20240424", "listing_expiration_date": "20261231"}